Ming Bai

1.2k total citations
57 papers, 839 citations indexed

About

Ming Bai is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ming Bai has authored 57 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Molecular Biology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ming Bai's work include Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (8 papers) and RNA modifications and cancer (6 papers). Ming Bai is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (8 papers) and RNA modifications and cancer (6 papers). Ming Bai collaborates with scholars based in China, United States and Greece. Ming Bai's co-authors include Yi Ba, Ting Deng, Haiyang Zhang, Tao Ning, Kegan Zhu, Guoguang Ying, Rui Liu, Shaohua Ge, Xia Chen and Xiaofang Che and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ming Bai

51 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Bai China 16 464 291 242 168 114 57 839
Xuequan Yao China 20 494 1.1× 305 1.0× 313 1.3× 172 1.0× 149 1.3× 37 921
Wenlei Zhuo China 20 580 1.3× 246 0.8× 342 1.4× 207 1.2× 143 1.3× 51 980
Dong Hoon Shin South Korea 16 491 1.1× 311 1.1× 271 1.1× 152 0.9× 64 0.6× 40 830
Vijesh Kumar Yadav Taiwan 18 502 1.1× 310 1.1× 173 0.7× 147 0.9× 62 0.5× 41 814
Jian Cai China 20 467 1.0× 308 1.1× 321 1.3× 289 1.7× 156 1.4× 42 974
Sarah Sarkar United States 12 486 1.0× 268 0.9× 356 1.5× 137 0.8× 76 0.7× 13 980
Shanshan Xiang China 15 682 1.5× 443 1.5× 210 0.9× 102 0.6× 161 1.4× 37 1.0k
Hong Yan China 21 593 1.3× 340 1.2× 317 1.3× 243 1.4× 160 1.4× 70 1.2k

Countries citing papers authored by Ming Bai

Since Specialization
Citations

This map shows the geographic impact of Ming Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Bai more than expected).

Fields of papers citing papers by Ming Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Bai. The network helps show where Ming Bai may publish in the future.

Co-authorship network of co-authors of Ming Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Bai. A scholar is included among the top collaborators of Ming Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Bai. Ming Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Rui, Zhi Ji, Xia Wang, et al.. (2025). Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial. Nature Communications. 16(1). 1481–1481. 5 indexed citations
2.
Bai, Ming, Peng Xu, Rong Cheng, et al.. (2025). ROS-ATM-CHK2 axis stabilizes HIF-1α and promotes tumor angiogenesis in hypoxic microenvironment. Oncogene. 44(21). 1609–1619. 2 indexed citations
3.
4.
Cao, Yang, Hairong Xu, Yinyan Gao, et al.. (2025). Efficacy of immune checkpoint inhibitors in the treatment of soft tissue sarcoma: A systematic review and meta-analysis of clinical trials. International Immunopharmacology. 148. 114070–114070. 2 indexed citations
5.
6.
Duan, Jingjing, Yinghui Shi, Weixue Wang, et al.. (2024). Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study. BMC Cancer. 24(1). 302–302. 3 indexed citations
7.
Tian, Shuo, Yagang Song, Jia Wang, et al.. (2023). Radix Salvia miltiorrhiza Ameliorates Burn Injuries by Reducing Inflammation and Promoting Wound Healing. Journal of Inflammation Research. Volume 16. 4251–4263. 4 indexed citations
8.
Liu, Ying, Meng C. Wang, Ting Deng, et al.. (2022). Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ. Cancer Biology and Medicine. 19(9). 1–14. 28 indexed citations
9.
Zhang, Haiyang, Zhengyang Zhou, Rui Liu, et al.. (2021). Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer. International Journal of General Medicine. Volume 14. 1185–1195. 10 indexed citations
10.
11.
Song, Na, Ming Bai, Xiaofang Che, et al.. (2020). PD-L1 upregulation accompanied with epithelial–mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells. Medical Oncology. 37(5). 47–47. 9 indexed citations
12.
Hsu, Jia‐Wei, Ming Bai, Kunhua Li, et al.. (2020). The protein kinase Akt acts as a coat adaptor in endocytic recycling. Nature Cell Biology. 22(8). 927–933. 18 indexed citations
13.
Wang, Xiaoxun, Xiaofang Che, Yibo Fan, et al.. (2018). Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1. Experimental Cell Research. 368(2). 184–193. 42 indexed citations
14.
Quan, Qi, Rui Li, Huiying Li, et al.. (2016). Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach. Acta Pharmacologica Sinica. 37(7). 963–972. 69 indexed citations
15.
Zeng, Liling, Ming Bai, Amit Mittal, et al.. (2013). Candidate Tumor Suppressor and pVHL Partner Jade-1 Binds and Inhibits AKT in Renal Cell Carcinoma. Cancer Research. 73(17). 5371–5380. 17 indexed citations
16.
Liu, Bin, Taixiang Liu, Ming Bai, et al.. (2013). Apigenin enhances the proliferative inhibition effect of aspirin in colon cancer cells by inhibiting COX-2. Clinical Oncology and Cancer Research. 40(8). 436–439. 1 indexed citations
17.
Wang, Haiyan, Jinbiao Gao, Ming Bai, et al.. (2013). The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer. Platelets. 25(5). 382–387. 61 indexed citations
18.
Deng, Ting, et al.. (2012). Overexpression of Cyclin L2 Inhibits Growth and Enhances Chemosensitivity in Human Gastric Cancer Cells. Asian Pacific Journal of Cancer Prevention. 13(4). 1425–1430. 11 indexed citations
19.
You, Yong, Ping Zou, Fang Liu, et al.. (2005). Expression of PPAR-? in Lung Cancer and the Role of PPAR-? in Apoptosis of Lung Cancer. The Chinese-German Journal of Clinical Oncology. 4(1). 36–39.
20.
Bai, Ming, et al.. (2001). FHIT gene expression in human urinary bladder transitional cell carcinomas.. PubMed. 15(2). 169–73. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuequan Yao Breakdown of academic impact, for papers by Wenlei Zhuo Breakdown of academic impact, for papers by Dong Hoon Shin Breakdown of academic impact, for papers by Vijesh Kumar Yadav Breakdown of academic impact, for papers by Jian Cai Breakdown of academic impact, for papers by Sarah Sarkar Breakdown of academic impact, for papers by Shanshan Xiang Breakdown of academic impact, for papers by Hong Yan
Rankless by CCL
2026